Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

L-Carnitine and Reduced Atherogenic Index

Doses used in studies

Tartrate · mg/day: 1,000 (median 1,000, IQR 1,000–1,000) — 1 study

Time to effect

Median: 8 weeks · IQR 8 weeks–8 weeks · Range 8 weeks–8 weeks — Reported in 1 of 1 study

1 of 1 paper

Modulatory Effects of Multi-species/Multi-strain Synbiotic and L-carnitine Concomitant Supplementation on Atherogenic-Indices, Body Composition, Visceral Obesity, and Appetite in Metabolically Healthy Women with Obesity: A Double-Blind Randomized Controlled Clinical Trial.
- 2025-02-08
- RCT
- Probiotics and antimicrobial proteins 17(6)
- - Farnoush Fallah
  - Reza Mahdavi
- PubMed: 39921845
- DOI: 10.1007/s12602-025-10460-2
12 Insights on
- Reduced Atherogenic Index
- High evidence
- Rigorous Journal
- Clinical
L-carnitine + synbiotic co-supplementation led to a significantly greater reduction in atherogenic-indices ... compared to L-carnitine mono-therapy.
Effect
Neutral
Effect size
Small
Significant
No
Dose
L-carnitine-tartrate 2 × 500 mg/day (monotherapy group)